-
Je něco špatně v tomto záznamu ?
Oligomeric state of hypoxanthine-guanine phosphoribosyltransferase from Mycobacterium tuberculosis
WS. Eng, DT. Keough, D. Hockova, DJ. Winzor, LW. Guddat,
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články
Odkazy
PubMed
28082125
DOI
10.1016/j.biochi.2016.12.020
Knihovny.cz E-zdroje
- MeSH
- chlorid hořečnatý farmakologie MeSH
- hypoxanthinfosforibosyltransferasa chemie metabolismus MeSH
- konformace proteinů účinky léků MeSH
- multimerizace proteinu účinky léků MeSH
- Mycobacterium tuberculosis enzymologie MeSH
- Publikační typ
- časopisecké články MeSH
Sedimentation equilibrium and size-exclusion chromatography experiments on Mycobacterium tuberculosis hypoxanthine-guanine phosphoribosyltransferase (MtHGPRT) have established the existence of this enzyme as a reversibly associating mixture of dimeric and tetrameric species in 0.1 M Tris-HCl-0.012 M MgCl2, pH 7.4. Displacement of the equilibrium position towards the larger oligomer by phosphate signifies the probable existence of MtHGPRT as a tetramer in the biological environment. These data thus add credibility to the relevance of considering enzyme function in the light of a published tetrameric structure deduced from X-ray crystallography. Failure of 5-phospho-α-d-ribosyl-1-pyrophosphate (PRib-PP) to perturb the dimer-tetramer equilibrium position indicates the equivalence and independence of binding for this substrate (the first to bind in an ordered sequential mechanism) to the two oligomers. By virtue of the displacement of the equilibrium position towards dimer that is affected by removing MgCl2 from the Tris-HCl buffer, it can be concluded that divalent metal ions, as well as phosphate, can affect the oligomerization. These characteristics of MtHGPRT in solution are correlated with published crystal structures of four enzyme-ligand complexes.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013304
- 003
- CZ-PrNML
- 005
- 20170428101243.0
- 007
- ta
- 008
- 170413s2017 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biochi.2016.12.020 $2 doi
- 035 __
- $a (PubMed)28082125
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Eng, Wai Soon $u School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia.
- 245 10
- $a Oligomeric state of hypoxanthine-guanine phosphoribosyltransferase from Mycobacterium tuberculosis / $c WS. Eng, DT. Keough, D. Hockova, DJ. Winzor, LW. Guddat,
- 520 9_
- $a Sedimentation equilibrium and size-exclusion chromatography experiments on Mycobacterium tuberculosis hypoxanthine-guanine phosphoribosyltransferase (MtHGPRT) have established the existence of this enzyme as a reversibly associating mixture of dimeric and tetrameric species in 0.1 M Tris-HCl-0.012 M MgCl2, pH 7.4. Displacement of the equilibrium position towards the larger oligomer by phosphate signifies the probable existence of MtHGPRT as a tetramer in the biological environment. These data thus add credibility to the relevance of considering enzyme function in the light of a published tetrameric structure deduced from X-ray crystallography. Failure of 5-phospho-α-d-ribosyl-1-pyrophosphate (PRib-PP) to perturb the dimer-tetramer equilibrium position indicates the equivalence and independence of binding for this substrate (the first to bind in an ordered sequential mechanism) to the two oligomers. By virtue of the displacement of the equilibrium position towards dimer that is affected by removing MgCl2 from the Tris-HCl buffer, it can be concluded that divalent metal ions, as well as phosphate, can affect the oligomerization. These characteristics of MtHGPRT in solution are correlated with published crystal structures of four enzyme-ligand complexes.
- 650 _2
- $a hypoxanthinfosforibosyltransferasa $x chemie $x metabolismus $7 D007041
- 650 _2
- $a chlorid hořečnatý $x farmakologie $7 D015636
- 650 _2
- $a Mycobacterium tuberculosis $x enzymologie $7 D009169
- 650 _2
- $a konformace proteinů $x účinky léků $7 D011487
- 650 _2
- $a multimerizace proteinu $x účinky léků $7 D055503
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Keough, Dianne T $u School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia.
- 700 1_
- $a Hockova, Dana $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i. Flemingovo nam. 2, CZ-166 10 Prague 6, Czechia.
- 700 1_
- $a Winzor, Donald J $u School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia.
- 700 1_
- $a Guddat, Luke W $u School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia. Electronic address: luke.guddat@uq.edu.au.
- 773 0_
- $w MED00009325 $t Biochimie $x 1638-6183 $g Roč. 135, č. - (2017), s. 6-14
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28082125 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170428101604 $b ABA008
- 999 __
- $a ok $b bmc $g 1199769 $s 974082
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 135 $c - $d 6-14 $e 20170109 $i 1638-6183 $m Biochimie $n Biochimie $x MED00009325
- LZP __
- $a Pubmed-20170413